62 related articles for article (PubMed ID: 21954597)
21. Gene expression profiles with cDNA microarray reveal RhoGDI as a predictive marker for paclitaxel resistance in ovarian cancers.
Goto T; Takano M; Sakamoto M; Kondo A; Hirata J; Kita T; Tsuda H; Tenjin Y; Kikuchi Y
Oncol Rep; 2006 May; 15(5):1265-71. PubMed ID: 16596196
[TBL] [Abstract][Full Text] [Related]
22. Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells.
Ko JC; Tsai MS; Chiu YF; Weng SH; Kuo YH; Lin YW
J Pharmacol Exp Ther; 2011 Jul; 338(1):184-94. PubMed ID: 21444628
[TBL] [Abstract][Full Text] [Related]
23. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.
Ibanez de Caceres I; Cortes-Sempere M; Moratilla C; Machado-Pinilla R; Rodriguez-Fanjul V; Manguán-García C; Cejas P; López-Ríos F; Paz-Ares L; de CastroCarpeño J; Nistal M; Belda-Iniesta C; Perona R
Oncogene; 2010 Mar; 29(11):1681-90. PubMed ID: 20023704
[TBL] [Abstract][Full Text] [Related]
24. Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.
Filipits M; Pirker R; Dunant A; Lantuejoul S; Schmid K; Huynh A; Haddad V; André F; Stahel R; Pignon JP; Soria JC; Popper HH; Le Chevalier T; Brambilla E
J Clin Oncol; 2007 Jul; 25(19):2735-40. PubMed ID: 17602078
[TBL] [Abstract][Full Text] [Related]
25. [P53 protein expression and chemosensitivity to cisplatin in patients with non-small cell lung cancer: a meta-analysis].
Wang JL; Jiao SC; Ye P; Li JY
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):770-3. PubMed ID: 18504201
[TBL] [Abstract][Full Text] [Related]
26. ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancer.
Bessho Y; Oguri T; Ozasa H; Uemura T; Sakamoto H; Miyazaki M; Maeno K; Sato S; Ueda R
Oncol Rep; 2009 Jan; 21(1):263-8. PubMed ID: 19082471
[TBL] [Abstract][Full Text] [Related]
27. Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy.
Ceppi P; Novello S; Cambieri A; Longo M; Monica V; Lo Iacono M; Giaj-Levra M; Saviozzi S; Volante M; Papotti M; Scagliotti G
Clin Cancer Res; 2009 Feb; 15(3):1039-45. PubMed ID: 19188177
[TBL] [Abstract][Full Text] [Related]
28. cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance.
Villeneuve DJ; Hembruff SL; Veitch Z; Cecchetto M; Dew WA; Parissenti AM
Breast Cancer Res Treat; 2006 Mar; 96(1):17-39. PubMed ID: 16322897
[TBL] [Abstract][Full Text] [Related]
29. Antitumor activity of hydrophilic Paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models.
Zou Y; Fu H; Ghosh S; Farquhar D; Klostergaard J
Clin Cancer Res; 2004 Nov; 10(21):7382-91. PubMed ID: 15534115
[TBL] [Abstract][Full Text] [Related]
30. The modifier subunit of glutamate cysteine ligase relates to cisplatin resistance in human small cell lung cancer xenografts in vivo.
Nishi M; Abe Y; Fujimori S; Hamamoto A; Inoue Y; Miyazaki N; Oida Y; Ikoma N; Ohnishi Y; Yamazaki H; Ueyama Y; Nakamura M
Oncol Rep; 2005 Aug; 14(2):421-4. PubMed ID: 16012725
[TBL] [Abstract][Full Text] [Related]
31. Class III Beta-tubulin Expression in Non-small Cell Lung Cancer: A Predictive Factor for Paclitaxel Response.
Ohashi T; Yoshimasu T; Oura S; Kokawa Y; Kawago M; Hirai Y; Miyasaka M; Aoishi Y; Kiyoi M; Nishiguchi H; Honda M; Okamura Y
Anticancer Res; 2015 May; 35(5):2669-74. PubMed ID: 25964544
[TBL] [Abstract][Full Text] [Related]
32. ATP-binding cassette B1 gene polymorphisms, mRNA expression and chemosensitivity to paclitaxel in non-small cell lung cancer cells.
Meng X; Wang G; Liu P; Hou J; Jin Y; Yu Y; Bai J; Chen F; Sun W; Fu S
Respirology; 2011 Nov; 16(8):1228-34. PubMed ID: 21883677
[TBL] [Abstract][Full Text] [Related]
33. MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer.
Oguri T; Ozasa H; Uemura T; Bessho Y; Miyazaki M; Maeno K; Maeda H; Sato S; Ueda R
Mol Cancer Ther; 2008 May; 7(5):1150-5. PubMed ID: 18445659
[TBL] [Abstract][Full Text] [Related]
34. Lower SLC7A2 expression is associated with enhanced multidrug resistance, less immune infiltrates and worse prognosis of NSCLC.
Jiang S; Zou J; Dong J; Shi H; Chen J; Li Y; Duan X; Li W
Cell Commun Signal; 2023 Jan; 21(1):9. PubMed ID: 36639771
[TBL] [Abstract][Full Text] [Related]
35. A systematic review of genes involved in the inverse resistance relationship between cisplatin and paclitaxel chemotherapy: role of BRCA1.
Stordal B; Davey R
Curr Cancer Drug Targets; 2009 May; 9(3):354-65. PubMed ID: 19442054
[TBL] [Abstract][Full Text] [Related]
36. Recent Advances in Elucidating Paclitaxel Resistance Mechanisms in Non-small Cell Lung Cancer and Strategies to Overcome Drug Resistance.
Cui H; Arnst K; Miller DD; Li W
Curr Med Chem; 2020; 27(39):6573-6595. PubMed ID: 33243106
[TBL] [Abstract][Full Text] [Related]
37. Clinical study of apatinib mesylate combined with paclitaxel injection and cisplatin injection in the treatment of non-small cell lung cancer.
Li F; You H; Chen L; Zou A; Mao Y
Minerva Surg; 2023 Apr; 78(2):235-237. PubMed ID: 35266680
[No Abstract] [Full Text] [Related]
38. Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum-paclitaxel chemotherapy.
Li Z; Qing Y; Guan W; Li M; Peng Y; Zhang S; Xiong Y; Wang D
Cancer Chemother Pharmacol; 2014 Oct; 74(4):777-86. PubMed ID: 25107571
[TBL] [Abstract][Full Text] [Related]
39. A bibenzyl from Dendrobium ellipsophyllum induces apoptosis in human lung cancer cells.
Hlosrichok A; Sumkhemthong S; Sritularak B; Chanvorachote P; Chaotham C
J Nat Med; 2018 Jun; 72(3):615-625. PubMed ID: 29488156
[TBL] [Abstract][Full Text] [Related]
40. Peptides extracted from edible mushroom: Lentinus squarrosulus induces apoptosis in human lung cancer cells.
Prateep A; Sumkhemthong S; Suksomtip M; Chanvorachote P; Chaotham C
Pharm Biol; 2017 Dec; 55(1):1792-1799. PubMed ID: 28532227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]